Wednesday, February 10, 2010, 6:09pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Micrus Endovascular Corp. (MEND)

At 5:00AM SGT: 18.60 USD   0.00 (0.00%)  
 MORE ON MEND 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Micrus Endovascular Corporation (NGM:MEND) Delayed quote dataEdit
Last Trade:18.60 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:18.60
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:17.02
Day's Range:N/A - N/A
52wk Range:4.13 - 18.78
Volume:0
Avg Vol (3m):93,071.4
Market Cap:297.71M
P/E (ttm):71.54
EPS (ttm):0.26
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add MEND to Portfolio   Download Data

 HEADLINES 
•Micrus Endovascular (MEND): Zacks Rank Buy
Zacks.com (Mon, Feb 8)
•New Star Analyst Rankings for Micrus Endovascular Corporation
StarMine (Sun, Feb 7)
•MICRUS ENDOVASCULAR CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Feb 6)
•Micrus Endovascular reports fiscal 3rd-qtr profit
AP (Fri, Feb 5)
•Micrus moves from Q3 loss to $3.3M profit
at bizjournals.com (Thu, Feb 4)
•MICRUS ENDOVASCULAR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Feb 4)
•Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20
Business Wire (Thu, Feb 4)
•Micrus Endovascular to Hold Fiscal 2010 Third Quarter Conference Call on February 4
Business Wire (Thu, Jan 28)
•Cashing In on Obamacare
at Motley Fool (Fri, Jan 22)
•Helen of Troy Ltd. (HELE): Zacks Rank Buy
Zacks.com (Mon, Jan 18)
•Zacks Releases Four Powerful ''Buy'' Stocks: Encore Capital Group, Inc., Harris Corp., Micrus Endovascular Corp. and Whirlpool Corporation
Zacks.com (Fri, Jan 15)
•Micrus Endovascular Corp. (MEND): Zacks Rank Buy
Zacks.com (Thu, Jan 14)
•Coverage initiated on Micrus Endovascular by Rodman & Renshaw
Briefing.com (Fri, Jan 8)
•Micrus Endovascular to Present at January Investment Conferences
Business Wire (Tue, Jan 5)
More Headlines for MEND...
 ANALYST 
EPS Est (next year) (Mar-10) :0.52
EPS Est (in 2 years) (Mar-11) :0.58
Avg Rec (current)*:1.6
PEG Ratio:0.74
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Micrus Endovascular Corporation develops, manufactures, and markets implantable and disposable medical devices to treat cerebral vascular diseases. It offers MicruSphere Microcoil, a framing coil that stabilizes the aneurysm; Presidio Microcoil, a...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices